Literature DB >> 21737885

Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.

Dallas Jones1, Laurie H Glimcher, Antonios O Aliprantis.   

Abstract

Over the past decade and a half, the biomedical community has uncovered a previously unappreciated reciprocal relationship between cells of the immune and skeletal systems. Work in this field, which has been termed "osteoimmunology," has resulted in the development of clinical therapeutics for seemingly disparate diseases linked by the common themes of inflammation and bone remodeling. Here, the important concepts and discoveries in osteoimmunology are discussed in the context of the diseases bridging these two organ systems, including arthritis, osteoporosis, cancer, and infection, and the targeted treatments used by clinicians to combat them.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737885      PMCID: PMC3223839          DOI: 10.1172/JCI46262

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  127 in total

1.  Clinical evaluation of onset of analgesia using intravenous pamidronate in metastatic bone pain.

Authors:  Eugen B Petcu; Stephan A Schug; H Smith
Journal:  J Pain Symptom Manage       Date:  2002-09       Impact factor: 3.612

2.  Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

Authors:  Guitty Eghbali-Fatourechi; Sundeep Khosla; Arunik Sanyal; William J Boyle; David L Lacey; B Lawrence Riggs
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation.

Authors:  Kenjiro Bandow; Aya Maeda; Kyoko Kakimoto; Joji Kusuyama; Mitsuo Shamoto; Tomokazu Ohnishi; Tetsuya Matsuguchi
Journal:  Biochem Biophys Res Commun       Date:  2010-10-29       Impact factor: 3.575

4.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  Inflammation and uncoupling as mechanisms of periodontal bone loss.

Authors:  D T Graves; J Li; D L Cochran
Journal:  J Dent Res       Date:  2010-12-06       Impact factor: 6.116

6.  Causative agents of osteomyelitis induce death domain-containing TNF-related apoptosis-inducing ligand receptor expression on osteoblasts.

Authors:  Amy B Young; Ian D Cooley; Vinita S Chauhan; Ian Marriott
Journal:  Bone       Date:  2010-12-03       Impact factor: 4.398

7.  Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Authors:  Daniel Schramek; Andreas Leibbrandt; Verena Sigl; Lukas Kenner; John A Pospisilik; Heather J Lee; Reiko Hanada; Purna A Joshi; Antonios Aliprantis; Laurie Glimcher; Manolis Pasparakis; Rama Khokha; Christopher J Ormandy; Martin Widschwendter; Georg Schett; Josef M Penninger
Journal:  Nature       Date:  2010-09-29       Impact factor: 49.962

8.  RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.

Authors:  Eva Gonzalez-Suarez; Allison P Jacob; Jon Jones; Robert Miller; Martine P Roudier-Meyer; Ryan Erwert; Jan Pinkas; Dan Branstetter; William C Dougall
Journal:  Nature       Date:  2010-09-29       Impact factor: 49.962

9.  Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression.

Authors:  Gisela Ruiz Heiland; Karin Zwerina; Wolfgang Baum; Trayana Kireva; Jörg H Distler; Mario Grisanti; Frank Asuncion; Xiadong Li; Michael Ominsky; William Richards; Georg Schett; Jochen Zwerina
Journal:  Ann Rheum Dis       Date:  2010-09-21       Impact factor: 19.103

10.  CTLA-4 directly inhibits osteoclast formation.

Authors:  R Axmann; S Herman; M Zaiss; S Franz; K Polzer; J Zwerina; M Herrmann; J Smolen; G Schett
Journal:  Ann Rheum Dis       Date:  2008-01-18       Impact factor: 19.103

View more
  38 in total

1.  Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study.

Authors:  Orla Ni Mhuircheartaigh; Cynthia S Crowson; Sherine E Gabriel; Veronique L Roger; L Joseph Melton; Shreyasee Amin
Journal:  J Rheumatol       Date:  2017-01-15       Impact factor: 4.666

Review 2.  The intestinal microbiome and skeletal fitness: Connecting bugs and bones.

Authors:  Julia F Charles; Joerg Ermann; Antonios O Aliprantis
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

3.  Increased Fragility Fracture Rates in Older Men With Osteomyelitis.

Authors:  Evelyn Hsieh; Stephanie Shiau; Olivia Nolan; Cynthia L Gibert; Roger J Bedimo; Maria C Rodriguez-Barradas; Amy C Justice; Julie A Womack; Michael T Yin
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

Review 4.  Bone and the innate immune system.

Authors:  Julia F Charles; Mary C Nakamura
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 5.  Gut Microbiome and Bone: to Build, Destroy, or Both?

Authors:  Jing Yan; Julia F Charles
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

6.  Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients.

Authors:  Theodoros Eleftheriadis; Efi Yiannaki; Vassilios Liakopoulos; Georgia Antoniadi; Georgios Pissas; Grammati Galaktidou; Ioannis Stefanidis
Journal:  Int Urol Nephrol       Date:  2013-01-08       Impact factor: 2.370

7.  RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.

Authors:  William O'Brien; Brian M Fissel; Yukiko Maeda; Jing Yan; Xianpeng Ge; Ellen M Gravallese; Antonios O Aliprantis; Julia F Charles
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

8.  A novel in vivo gene transfer technique and in vitro cell based assays for the study of bone loss in musculoskeletal disorders.

Authors:  Dennis J Wu; Neha Dixit; Erika Suzuki; Thanh Nguyen; Hyun Seock Shin; Jack Davis; Emanual Maverakis; Iannis E Adamopoulos
Journal:  J Vis Exp       Date:  2014-06-08       Impact factor: 1.355

9.  Gut microbiota induce IGF-1 and promote bone formation and growth.

Authors:  Jing Yan; Jeremy W Herzog; Kelly Tsang; Caitlin A Brennan; Maureen A Bower; Wendy S Garrett; Balfour R Sartor; Antonios O Aliprantis; Julia F Charles
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

10.  Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials.

Authors:  Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Yang Yao; Zan Shen
Journal:  Int J Clin Oncol       Date:  2013-04-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.